Search Within

Alexander Noor Shoushtari

Formats
  1. Journal Article (113)
  2. Meeting Abstract (106)
  3. Research Letter (11)
  4. Editorial (7)
  5. Review (4)
  6. Book Section (3)
  7. Guidelines (1)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (246)
  2. Hematologic Malignancies, Division of (246)
  3. Melanoma Disease Management Team (246)
  4. Melanoma and Immunotherapeutics Service (246)
  5. Solid Tumor Oncology Division (246)
  6. GSK Faculty (87)

More Groups

People
  1. Michael Postow (63)
  2. Jedd Wolchok (49)
  3. Margaret Callahan (45)
  4. Paul Chapman (45)
  5. Katherine Panageas (35)
  6. Parisa Momtaz (32)

More People

Years
  1. 2025 (6)
  2. 2024 (22)
  3. 2023 (25)
  4. 2022 (38)
  5. 2021 (38)
  6. 2020 (28)

More Years

Publications
  1. Journal of Clinical Oncology (67)
  2. Annals of Oncology (22)
  3. Journal for ImmunoTherapy of Cancer (17)
  4. Clinical Cancer Research (11)
  5. Cancer Research (7)
  6. Melanoma Research (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (70)
  2. Oxford University Press (29)
  3. American Association for Cancer Research (21)
  4. Biomed Central Ltd (21)
  5. Nature Publishing Group (15)
  6. Elsevier Inc. (13)

More Publishers

Results (246)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Disruption of TAD hierarchy promotes LTR co-option in cancer
    Journal Article

    Wong, E. W. P.; Sahin, M.; Yang, R.; Lee, U.; Li, D.; Zhan, Y. A.; Misra, R.; Tomas, F.; Alomran, N.; Polyzos, A.; more...
    Nature Genetics (2025)

    Fulltext@MSK | Save
  • Effect of post-discharge symptom monitoring on hospital readmissions: A randomized trial
    Meeting Abstract

    Daly, R. M.; Mao, J. J.; Cracchiolo, J. R.; Holland, J. C.; Huang, J.; Ebstein, A. M.; Walters, C.; Ackerman, J.; Raj, N. P.; Sanford, R. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Evolution of the tumor immune landscape during treatment with tebentafusp, a T cell receptor-CD3 bispecific
    Journal Article

    Sacco, J. J.; Kirk, P.; Leach, E.; Shoushtari, A. N.; Carvajal, R. D.; Britton-Rivet, C.; Khakoo, S.; Collins, L.; de la Cruz-Merino, L.; Eroglu, Z.; more...
    Cell Reports Medicine (2025)

    Fulltext@MSK | Save
  • Intracranial outcomes of ipilimumab and nivolumab in melanoma brain metastases after progression on anti-PD-1 therapy
    Research Letter

    Lochrin, S. E.; Kalvin, H. L.; Smithy, J. W.; Chen, M. F.; Momtaz, P.; Shoushtari, A. N.; Panageas, K. S.; Postow, M. A.
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Tumor-infiltrating lymphocyte therapy for melanoma and other solid tumors: Looking back, yet moving forward
    Review

    Shoushtari, A. N.; Powell, D. J.
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Next-generation sequencing for HLA genotype screening and matching to HLA-restricted therapies
    Research Letter

    Gormally, M. V.; Chen, M. F.; Noronha, A. M.; Panageas, K.; Reynolds, M.; Kohlasch, K.; Novak, B.; Kee-Velez, T.; Clarke, N.; Eubank, M.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Immune checkpoint inhibitor rechallenge after treatment with tumor-infiltrating lymphocytes in unresectable melanoma
    Meeting Abstract

    Betof Warner, A.; Smithy, J. W.; Los, C.; Kalvin, H.; Hasson, N.; Amaria, R. N.; Andrade Czapla, J. A.; Schollenberger, M.; furness, A.; Hassel, J. C.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy of LNS8801 in melanoma patients with prior immune-related adverse events from immune-checkpoint inhibitors
    Meeting Abstract

    Cohen, J. V.; Garyantes, T. K.; Muller, C.; Natale, C. A.; Orloff, M.; Patel, S.; Rodon, J.; Shoushtari, A. N.
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Association of a blood T cell fitness gene signature with clinical benefit from ImmTAC bispecific T cell engagers
    Meeting Abstract

    Sacco, J. J.; Carvajal, R. D.; Hamid, O.; Kirk, P. B.; Collins, L.; Butler, M. O.; Shoushtari, A. N.; Hassel, J. C.; Ikeguchi, A. P.; Hernandez-Aya, L.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Trial in progress: Phase 1/2 study of OBX-115 engineered tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced solid tumors
    Meeting Abstract

    Schoenfeld, A. J.; Warner, A. B.; Chesney, J. A.; Thomas, S. S.; Moyers, J. T.; In, G. K.; Shoushtari, A. N.; Samhouri, Y.; Hari, P.; Ramsingh, G.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save